Racial/ethnic disparities and geographic clustering in pediatric thyroid cancer incidence in the United States, 1999–2022, with forecasts to 2027

Pediatric and adolescent thyroid cancer incidence rose steadily in the U.S. from 1999 to 2022, with pronounced socio-demographic heterogeneity and a notable diagnostic disruption in 2020. Continued surveillance and investigation of etiologic drivers and diagnostic intensity are mandatory, alongside efforts to reduce inequities in access to evaluation and care.